Skip to main content
SpringerLink
Log in

Analysis of renal impairment in children with Wilson’s disease

  • Original Article
  • Published:
World Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Background

Since the diverse manifestations of renal impairment appear in different periods of Wilson’s disease, misdiagnosis or missed diagnosis is not rare. This study was undertaken to find the clinical features of renal impairment in children with Wilson’s disease or hepatolenticular degeneration (HLD).

Methods

Eighty-five children with HLD who had been treated at our department between January 1991 and June 2006 were retrospectively studied. The clinical data of 25 patients with renal impairment were analyzed.

Results

In the 85 HLD patients, 34 had renal impairment. Nine of the 34 patients with D-penicillamine treatment were excluded. In the remaining 25 patients, 7 had initiated symptoms of renal impairment, 5 of them with edema, 1 with gross hematuria, and 1 with acute hemolysis and acute renal failure. Twelve of the 25 patients had proteinuria, 14 had hematuria, and 5 had both proteinuria and hematuria. Urine glucose was positive in 4 patients, urine N-acetyl-β-D-glucosaminidase (NAG) increased in 5, and urine β2-microglobulin increased in 6. Urine red blood cell (RBC) phase was detected in 7 patients, including glomerular hematuria in 5 patients and non-glomerular hematuria in 2. Blood urea nitrogen and creatinine increased in 1 patient. B-ultrasound revealed bilaterally enlarged kidneys in 3 patients. Kidney biopsy showed diffuse mesangial proliferation and IgA deposit in mesangial region in 1 patient. All of the 25 patients had cornea K-F ring and the level of ceruloplasmin decreased. Six patients had a family history of HLD.

Conclusions

The manifestations of renal impairment with HLD are varied. HLD should be excluded from patients with unexplained renal impairment, while those with HLD should take examinations of the kidney to identify renal impairment. We propose that renal function and urinalysis should be checked regularly in patients receiving treatment of D-penicillamine.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Medici V, Rossaro L, Sturniolo GC. Wilson disease—a practical approach to diagnosis, treatment and follow-up. Dig Liver Dis 2007;39:601–609.

    Article  PubMed  CAS  Google Scholar 

  2. Prashanth LK, Taly AB, Sinha S, Arunodaya GR, Swamy HS. Wilson’s disease: diagnostic errors and clinical implications. J Neurol Neurosurg Psychiatry 2004;75:907–909.

    Article  PubMed  CAS  Google Scholar 

  3. Kitzberger R, Madl C, Ferenci P. Wilson disease. Metab Brain Dis 2005;20:295–302.

    Article  PubMed  Google Scholar 

  4. Ferenci P. Wilson’s disease. Clin Gastroenterol Hepatol 2005; 3:726–733.

    Article  PubMed  CAS  Google Scholar 

  5. Schwarzenberg SJ, Sharp HL. Pediatric gastroenterology. Update on metabolic liver disease. Pediatr Clin North Am 1996;43:27–56.

    Article  PubMed  CAS  Google Scholar 

  6. El-Youssef M. Wilson Disease. Mayo Clin Proc 2003;78: 1126–1136.

    PubMed  CAS  Google Scholar 

  7. Sozeri E, Feist D, Ruder H, Scharer K. Proteinuria and other renal functions in Wilson’s disease. Pediatr Nephrol 1997;11: 307–311.

    Article  PubMed  CAS  Google Scholar 

  8. Voskaridou E, Terpos E, Michail S, Hantzi E, Anagnostopoulos A, Margeli A, et al. Early markers of renal dysfunction in patients with sickle cell/beta-thalassemia. Kidney Int 2006;69:2037–2042.

    Article  PubMed  CAS  Google Scholar 

  9. Sarles J, Durand JM, Scheiner C, Picon G. Wilson disease, IgA glomerulonephritis and vascular purpura: an incidental association? Arch Fr Pediatr 1993;50:501–504.

    PubMed  CAS  Google Scholar 

  10. Behrman RE, Kliegman RM, Jenson HB. Nelson Textbook of Pediatrics. Wilson Disease. 16th ed. Philadelphia: W. B. Sounders Company, 2000: 1209.

    Google Scholar 

  11. Gunduz Z, Dusunsel R, Anarat A. Wilson cirrhosis associated with membranoproliferative glomerulonephritis. Nephron 1996;74:497–498.

    Article  PubMed  CAS  Google Scholar 

  12. Nanke Y, Akama H, Terai C, Kamatani N. Rapidly progressive glomerulonephritis with D-penicillamine. Am J Med Sci 2000;320:398–402.

    Article  PubMed  CAS  Google Scholar 

  13. Habib GS, Saliba W, Nashashibi M, Armali Z. Penicillamine and nephrotic syndrome. Eur J Intern Med 2006;17:343–348.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510080, China

    Xiao-Hui Zhuang, Ying Mo, Xiao-Yun Jiang & Shu-Mei Chen

Authors
  1. Xiao-Hui Zhuang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ying Mo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xiao-Yun Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Shu-Mei Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ying Mo.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhuang, XH., Mo, Y., Jiang, XY. et al. Analysis of renal impairment in children with Wilson’s disease. World J Pediatr 4, 102–105 (2008). https://doi.org/10.1007/s12519-008-0019-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12519-008-0019-5

Key words

Search

Navigation